Form CORRESP - Correspondence:
SEC Accession No. 0001493152-23-034607
Filing Date
2023-09-28
Accepted
2023-09-28 15:11:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 17097
  Complete submission text file 0001493152-23-034607.txt   18215
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

EIN.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations